Literature DB >> 5652975

Generalized scleroderma. Treatment with an immunosuppressive agent.

G T Jansen, D F Barraza, J L Ballard, W M Honeycutt, C J Dillaha.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 5652975     DOI: 10.1001/archderm.97.6.690

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  6 in total

Review 1.  Effects of immunomodulating therapy in systemic sclerosis.

Authors:  F H van den Hoogen; A M Boerbooms; L B van de Putte
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

Review 2.  Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics.

Authors:  A Anstey
Journal:  J R Soc Med       Date:  1995-03       Impact factor: 5.344

3.  Intravenous dexamethasone pulse therapy in diffuse systemic sclerosis. A randomized placebo-controlled study.

Authors:  B Sharada; A Kumar; R Kakker; C M Adya; I Pande; S S Uppal; J N Pande; K R Sunderam; A N Malaviya
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

Review 4.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 5.  Treatment of systemic sclerosis.

Authors:  T A Medsger
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

6.  Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine.

Authors:  D E Furst; P J Clements; R Harris; M Ross; J Levy; H E Paulus
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.